The Association of British Insurers has been forced to change the terms of its Statement of Best Practice on critical illness cover to make it clear two rare forms of cancer will be covered by the recent changes.
New medical evidence about two rare forms of cancer affecting the blood, known as essential thrombocythaemia and polycythaemia rubra vera, has forced the ABI to change its recently-announced definitions of conditions covered by CIC as they were previously left out of the list of conditions which are to be covered by policies. They were previously included within the Statement of Best Practice as definitions of conditions listed as ‘pre-malignancy’ and therefore not eligible to be listed as critical illnesses. However, new evidence means in some cases a patient's cancer can be malignant, w...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes